Medical Cannabis Flower
Strain-level COA, terpene and cannabinoid profile per batch, storage and grinding guidance, and dosing titration authored with the prescribing clinic.
No. Cannabis-based products for medicinal use (CBPMs) are prescription-only medicines under the UK's specials route, and advertising POMs to the general public is prohibited by regulation 279 of the Human Medicines Regulations 2012 and the MHRA Blue Guide. The equivalent EU rule is Article 88 of Directive 2001/83/EC. SmartLinks builds the portal as patient-only content — PIL, batch, dosing, safety, refill — never as consumer marketing.
Consumer-style engagement — points, referral bounties, discount codes, cross-sell — is inappropriate for a scheduled POM and can be treated as unlawful promotion or inducement. The medical cannabis flow deliberately replaces those mechanics with clinic-mediated refill, adherence diary and prescriber-authored education. The CBD page is where consumer mechanics live for the non-POM cannabinoid range.
Yes. The MHRA best-practice guidance on patient information leaflets supports digital PIL alongside paper, and the EMA electronic product information (ePI) framework is heading the same way for centrally-authorised products. SmartLinks routes the digital PIL for the exact batch and product a patient scans.
The portal offers a one-tap route to the MHRA Yellow Card scheme, prefilled with the product name, batch and serial from the scan — reducing friction for patients and prescribers reporting suspected adverse reactions.
Refill requests are routed to the patient's prescribing clinic (not a shop cart), with prescription and identity verification before any dispensing conversation. The pack triggers the request; the clinic remains the authoriser — keeping the flow inside the specials-route and prescriber-of-record framework.
Key Features
Everything You Need, Built In — Discover how SmartLinks™ technology enhances every aspect of your products

Deliver the electronic PIL for the exact product and batch in the patient's hand — multilingual, accessibility-ready, and always the current version.

Patient Engagement & Adherence for Prescription Cannabis
Medical cannabis is a prescription-only medicine. UK advertising to the public is prohibited under the Human Medicines Regulations 2012 and the MHRA Blue Guide; the EU equivalent is Directive 2001/83/EC Title VIII. SmartLinks™ deliberately replaces consumer loyalty and discount mechanics with clinic-authorised patient-support tools.
01
Private, patient-owned log of doses, timing and effects that the patient can choose to share with their prescribing clinician — supporting titration and outcome reviews.
02
Refill requests are routed to the patient's clinic, never to a consumer checkout. No cross-sell, no discount code, no loyalty points — by design.
03
Educational content on safe use, storage, driving and interactions, authored with the prescribing clinic — patient-support material, not brand advertising.
04
Structured post-dose feedback shared back to the prescriber rather than public reviews — closing the loop on titration without breaching POM advertising rules.
How It Works
Go live in under an hour — no complex integration required

Use Cases
Strain-level COA, terpene and cannabinoid profile per batch, storage and grinding guidance, and dosing titration authored with the prescribing clinic.
Servings and titration guidance, batch potency, digital PIL and clinic-mediated refill for prescription cannabis oils and sprays.
Serial-level tamper-evidence, device compatibility, safe-use guidance and Yellow Card reporting for prescribed cannabis vape products.
Dose-per-unit clarity, adherence support, batch traceability and refill request routing for standardised prescription cannabis capsules.
Dispensing-side view of scans and adherence, recall push, and a single patient-facing portal across the clinic's formulary — no separate app rollout.
Serial and batch-level recall push directly to patients holding affected packs, plus prefilled Yellow Card ADR reporting and audit-ready scan history.
Health & Beauty · Medical Cannabis
SmartLinks™ turns every prescription cannabis pack into a patient-only portal — digital PIL, batch and strain COA, dosing titration, Yellow Card reporting and clinic-mediated refill, without any consumer marketing layer.

Book a walkthrough to see SmartLinks across your CBPM range — digital PIL, batch COA, Yellow Card reporting and clinic-mediated refill, without any consumer marketing layer.